Advisory council and scientific review meetings associated with the NIH's grant making process, in which outside scientists provide a final grant review and strategic advice before the finalization of ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 ... statements” that are subject to substantial risks ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

United Therapeutics Corporation , a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant prostate cancer ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ETCompany ParticipantsYvonne Perron - Vice President, FP&A ...

Large language models (LLMs) are poised to have a disruptive impact on health care. Numerous studies have demonstrated ...

as well as several federal grants from the NIH and USAMRDC. hVIVO plc (Ticker: HVO) is a rapidly growing early-stage Contract Research Organisation (CRO) and the global leader in human challenge ...

In an effort to promote upcoming free school vaccine clinics, the Harwood Unified Union School District is participating in a ...

After two decades of work in biomedical research policy, there is no topic Carrie Wolinetz hates talking about more than ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...